Collaborations Pharmaceuticals, Inc.: A small company focused on rare and neglected disease drug discovery

被引:0
|
作者
Zorn, Kimberley [1 ]
Lane, Thomas [1 ]
Hupcey, Maggie [1 ]
Ekins, Sean [1 ]
机构
[1] Collaborat Pharmaceut, Fuquay Varina, NC USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
11
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Neuromedica, Inc. - Company combines drug delivery and drug discovery
    Lewis, R
    GENETIC ENGINEERING NEWS, 1998, 18 (14): : 28 - +
  • [2] Iconix Pharmaceuticals, Inc. - removing barriers to efficient drug discovery through chemogenomics
    Engelberg, A
    PHARMACOGENOMICS, 2004, 5 (06) : 741 - 744
  • [3] Industrializing neglected and rare disease drug discovery and development
    Lingerfelt, Mary
    Zorn, Kimberley
    Hupcey, Maggie
    Ekins, Sean
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [4] St. Charles Pharmaceuticals Inc.: A start-up company.
    Bazan, NG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U694 - U695
  • [5] How can PubChem be leveraged for neglected and rare disease drug discovery?
    Bolton, Evan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [6] Progress in Neglected Disease Drug Discovery
    Hopkins, Andrew L.
    Wyatt, Paul G.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (10) : 1215 - 1215
  • [8] Incentives for Starting Small Companies Focused on Rare and Neglected Diseases
    Ekins, Sean
    Wood, Jill
    PHARMACEUTICAL RESEARCH, 2016, 33 (04) : 809 - 815
  • [9] Incentives for Starting Small Companies Focused on Rare and Neglected Diseases
    Sean Ekins
    Jill Wood
    Pharmaceutical Research, 2016, 33 : 809 - 815
  • [10] Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease
    Jonathan Cechetto
    Hee Kyoung Jeon
    Jiyeon Jang
    Doyoon Kwon
    Thierry Christophe
    Priscille Brodin
    Gyongseon Yang
    Jair Neto
    Lucio Freitas Junior
    BMC Proceedings, 5 (Suppl 1)